Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease

Clinical trial NCT01562041 · TERMINATED

Trial details

NCT number: NCT01562041
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerotic Coronary Vascular Disease

Start date: 2012-03-09
Primary completion: 2014-01-02
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.